![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » NOVO NORDISK SUES PFIZER FOR PATENT INFRINGEMENT
NOVO NORDISK SUES PFIZER FOR PATENT INFRINGEMENT
August 2, 2006
Novo Nordisk announced that the company filed a lawsuit against Pfizer claiming that Pfizer's product Exubera infringes on patents owned by Novo Nordisk. The patents cover inhaled insulin treatment for diabetes.
PR
Newswire
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct